Henry Clement Pitot, MD

  • 12490 Citations
  • 46 Scopus h-Index
1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Henry Clement Pitot is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 12490 Citations
  • 46 Scopus h-Index
  • 87 Article
  • 3 Letter
  • 2 Review article
  • 1 Editorial

Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer

Childs, D. S., Yoon, H. H., Eiring, R. A., Jin, Z., Jochum, J. A., Pitot, H. C. & Jatoi, A., Jan 1 2020, (Accepted/In press) In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

  • Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

    McCleary-Wheeler, A. L., Carr, R. M., Palmer, S. R., Smyrk, T. C., Allred, J. B., Almada, L. L., Tolosa, E. J., Lamberti, M. J., Marks, D. L., Borad, M. J., Molina, J. R., Qi, Y., Lingle, W. L., Grothey, A., Pitot, H. C., Jatoi, A., Northfelt, D. W., Bryce, A. H., McWilliams, R. R., Okuno, S. H. & 10 others, Haluska, P., Kim, G. P., Colon-Otero, G., Lowe, V. J., Callstrom, M. R., Ma, W. W., Bekaii-Saab, T., Hung, M. C., Erlichman, C. & Fernandez-Zapico, M. E., Jan 2020, In : Pancreatology. 20, 1, p. 101-109 9 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone

    Wang, L., Dehm, S. M., Hillman, D. W., Sicotte, H., Tan, W., Gormley, M., Bhargava, V., Jimenez, R., Xie, F., Yin, P., Qin, S., Quevedo, F., Costello, B. A., Pitot, H. C., Ho, T., Bryce, A. H., Ye, Z., Li, Y., Eiken, P., Vedell, P. T. & 16 others, Barman, P., McMenomy, B. P., Atwell, T. D., Carlson, R. E., Ellingson, M., Eckloff, B. W., Qin, R., Ou, F., Hart, S. N., Huang, H., Jen, J., Wieben, E. D., Kalari, K. R., Weinshilboum, R. M., Wang, L. & Kohli, M., Feb 1 2018, In : Annals of Oncology. 29, 2, p. 352-360 9 p.

    Research output: Contribution to journalArticle

  • 25 Scopus citations

    Androgen receptor variant AR-V9 is coexpressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance

    Kohli, M., Ho, Y., Hillman, D. W., Van Etten, J. L., Henzler, C., Yang, R., Sperger, J. M., Li, Y., Tseng, E., Hon, T., Clark, T., Tan, W., Carlson, R. E., Wang, L., Sicotte, H., Thai, H., Jimenez, R., Huang, H., Vedell, P. T., Eckloff, B. W. & 9 others, Quevedo, J. F., Pitot, H. C., Costello, B. A., Jen, J., Wieben, E. D., Silverstein, K. A. T., Lang, J. M., Wang, L. & Dehm, S. M., Aug 15 2017, In : Clinical Cancer Research. 23, 16, p. 4704-4715 12 p.

    Research output: Contribution to journalArticle

  • 55 Scopus citations

    Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat; a phase 2 consortium/stand Up 2 cancer study

    Azad, N. S., El-Khoueiry, A., Yin, J., Oberg, A. L., Flynn, P., Adkins, D., Sharma, A., Weisenberger, D. J., Brown, T., Medvari, P., Jones, P. A., Easwaran, H., Kamel, I., Bahary, N., Kim, G., Picus, J., Pitot, H. C., Erlichman, C., Donehower, R., Shen, H. & 4 others, Laird, P. W., Piekarz, R., Baylin, S. & Ahuja, N., 2017, In : Oncotarget. 8, 21, p. 35326-35338 13 p.

    Research output: Contribution to journalArticle

  • 26 Scopus citations